Minu K. Srivastava
ORCID：0009-0000-3827-9180
发表论文 113 篇 · 总被引 2997 次 · h-index 22
代表论文
- Five-Year Survival Outcomes With Atezolizumab After Chemotherapy in Resected Stage IB-IIIA Non–Small Cell Lung Cancer (IMpower010): An Open-Label, Randomized, Phase III Trial (2025 · Journal of Clinical Oncology · 被引 51)
- Atezolizumab plus bevacizumab and chemotherapy in metastatic nonsquamous NSCLC: the randomized double-blind phase 3 IMpower151 trial (2025 · Nature Medicine · 被引 36)
- Digital Versus Manual PD-L1 Scoring in Advanced NSCLC From the IMpower110 and IMpower150 Trials (2025 · Journal of Thoracic Oncology · 被引 7)
- Non-small cell lung cancer molecular subtypes and vulnerability to immunotherapy treatment combinations (2025 · Nature Communications · 被引 5)
- Brief Report: Post Hoc Validation of Platinum Ineligibility in NSCLC From the Phase III IPSOS Study (2025 · Journal of Thoracic Oncology · 被引 5)
- Clonal hematopoiesis is associated with reduced response to atezolizumab in non-small cell lung cancer (2025 · Journal for ImmunoTherapy of Cancer · 被引 3)